Detalles de la búsqueda
1.
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens.
Antimicrob Agents Chemother
; 68(4): e0140023, 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38415667
2.
Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Lipids Health Dis
; 14: 99, 2015 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26328782
3.
A single-dose, 3-way crossover pharmacokinetic comparison between immediate-release oxycodone hydrochloride with aversion technology (IRO-A, Oxecta), IRO-a with Niacin, and Oxycodone Hydrochloride (Roxicodone) in healthy adults under fasting conditions.
Am J Ther
; 21(2): 99-105, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-22357166
4.
The advent of a new pseudoephedrine product to combat methamphetamine abuse.
Am J Drug Alcohol Abuse
; 39(5): 284-90, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23968171
5.
Pharmacokinetics, Metabolism, and Excretion of Intravenous [14C]Difelikefalin in Healthy Subjects and Subjects on Hemodialysis.
Clin Pharmacokinet
; 62(9): 1231-1241, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37369955
6.
Phase I studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of DS-1211, a tissue-nonspecific alkaline phosphatase inhibitor.
Clin Transl Sci
; 15(4): 967-980, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35021269
7.
Phase 1 Clinical Trials of Small Molecules: Evolution and State of the Art.
Rev Recent Clin Trials
; 16(3): 232-241, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33563172
8.
A Single-Dose, Two-Way Crossover, Open-Label Bioequivalence Study of an Amphetamine Extended-Release Oral Suspension in Healthy Adults.
J Atten Disord
; 24(3): 414-419, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29192549
9.
Evaluation of the administration time effect on the cumulative cortisol suppression and cumulative lymphocytes suppression for once-daily inhaled corticosteroids: a population modeling/simulation approach.
J Clin Pharmacol
; 48(9): 1069-80, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18728243
10.
Metabolism, distribution and elimination of lisdexamfetamine dimesylate: open-label, single-centre, phase I study in healthy adult volunteers.
Clin Drug Investig
; 28(12): 745-55, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18991468
11.
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Preschool-Aged Children.
J Child Adolesc Psychopharmacol
; 28(9): 606-614, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30388032
12.
Fed and Fasted Administration of a Novel Extended-Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD.
Clin Pharmacol Drug Dev
; 7(2): 160-167, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28544344
13.
Pharmacokinetics of a New Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder.
J Child Adolesc Psychopharmacol
; 28(1): 29-35, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28933918
14.
A Comparison of the Pharmacokinetics of Methylphenidate Extended-Release Orally Disintegrating Tablets With a Reference Extended-Release Formulation of Methylphenidate in Healthy Adults.
Clin Pharmacol Drug Dev
; 7(2): 151-159, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28544581
15.
Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
Clin Ther
; 39(12): 2389-2398, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29174216
16.
Pharmacokinetics of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Children with Attention-Deficit/Hyperactivity Disorder.
J Child Adolesc Psychopharmacol
; 27(3): 216-222, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27936898
17.
A Randomized Phase I Study to Assess the Effect of Alcohol on the Pharmacokinetics of an Extended-release Orally Disintegrating Tablet Formulation of Amphetamine in Healthy Adults.
Clin Ther
; 39(8): 1695-1705, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28760535
18.
Safety and efficacy considerations due to misuse of extended-release formulations of stimulant medications.
Postgrad Med
; 128(7): 672-81, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27467139
19.
A randomized crossover study to assess the pharmacokinetics of a novel amphetamine extended-release orally disintegrating tablet in healthy adults.
Postgrad Med
; 128(7): 648-55, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27488574
20.
A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
J Child Adolesc Psychopharmacol
; 26(6): 505-12, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27228207